February 26, 2024 Comments Off on Cost-Cut Without Compromise: Navigating Excipient Switching in Pharma Posted in: Uncategorized
Switching pharmaceutical excipients, the inactive components used in drug formulations, can have significant implications for both production costs and market appeal. These components, while not contributing directly to the therapeutic…
The post Cost-C…
February 26, 2024 Comments Off on New patent expiration for Endo Pharms drug NASCOBAL Posted in: Uncategorized
Annual Drug Patent Expirations for NASCOBAL Nascobal is a drug marketed by Par Pharm and Endo Pharms Inc and is included in two NDAs. It is available from one supplier.…
The post New patent expiration for Endo Pharms drug NASCOBAL appeared first on Dru…
